Publication:
Medicines use review service in community pharmacies in Spain: REVISA project.

dc.contributor.authorGarcía-Agua Soler, Nuria
dc.contributor.authorGómez-Bermúdez, Eugenia
dc.contributor.authorBaixauli-Fernández, Vicente J
dc.contributor.authorBellver-Beltrán, Sara
dc.contributor.authorVelasco-Martínez, Javier
dc.contributor.authorGarcía Ruiz, Antonio J
dc.contributor.authorJódar-Sánchez, Francisco
dc.date.accessioned2024-02-12T19:47:29Z
dc.date.available2024-02-12T19:47:29Z
dc.date.issued2020-09-29
dc.description.abstractBackground Community pharmacy services play an important role in controlling some factors related to medicine use and patients can benefit from these services to improve the adherence and knowledge of their medications, besides to reduce medicine-related problems. Objective The aim of the REVISA project is to carry out a study on preliminary implementation of the medicines use review service in Spanish community pharmacies. Setting Sixty-four community pharmacies from all regions of Spain. Method A preliminary implementation, cross-sectional multicentre study was conducted using a convenience sample of voluntary community pharmacies. A structured interview enabled to pharmacists to obtain a better understanding of patient's medicines use. Main outcome measure Medicines use review-related time and cost, satisfaction and willingness to pay. Results A total of 495 patients were enrolled. The mean age of the patients was 66.1 years, with the majority females (56.4%) and a mean consumption of 5.7 medicines. A total of 2811 medicines were evaluated and 550 referral recommendations were made (29.8% to Primary Care). The mean time employed by the pharmacists in the medicines use review service was 52.8 min (medicines use review-related cost of €17.27). Most patients expressed a high level of satisfaction with this service (98.5%) and a willingness to pay for it (84%). Conclusion Medicines use review service in community pharmacies in Spain can be delivered, that it appears to be acceptable to patients and that most patients said they would be willing to pay for it. This service may offer an opportunity to promote inter-professional collaboration between pharmacists and general practitioners.
dc.format.number3es_ES
dc.format.page524-531es_ES
dc.format.volume43es_ES
dc.identifier.doi10.1007/s11096-020-01158-2
dc.identifier.e-issn2210-7711es_ES
dc.identifier.journalInternational journal of clinical pharmacyes_ES
dc.identifier.otherhttp://hdl.handle.net/10668/16351
dc.identifier.pubmedID32996076es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/18128
dc.language.isoeng
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAdherence
dc.subjectCommunity pharmacies
dc.subjectMedicines use review
dc.subjectPolypharmacy
dc.subjectWillingness to pay
dc.subject.meshCommunity Pharmacy Services
dc.subject.meshCross-Sectional Studies
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshInfant, Newborn
dc.subject.meshPharmacies
dc.subject.meshPharmacists
dc.subject.meshProfessional Role
dc.subject.meshSpain
dc.titleMedicines use review service in community pharmacies in Spain: REVISA project.
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files